BR9712548A - Processo para identificar uma célula eritrócita ou eritroblástica fetal em uma amostra sanguìnea, kit para identificação de uma célula eritrócita ou eritroblástica nucleada fetal, e, kit para seleção ou isolamento de uma sequência de ácida nucléico dentro de uma célula eritrócita ou eritroblástica nucleada fetal. - Google Patents

Processo para identificar uma célula eritrócita ou eritroblástica fetal em uma amostra sanguìnea, kit para identificação de uma célula eritrócita ou eritroblástica nucleada fetal, e, kit para seleção ou isolamento de uma sequência de ácida nucléico dentro de uma célula eritrócita ou eritroblástica nucleada fetal.

Info

Publication number
BR9712548A
BR9712548A BR9712548-2A BR9712548A BR9712548A BR 9712548 A BR9712548 A BR 9712548A BR 9712548 A BR9712548 A BR 9712548A BR 9712548 A BR9712548 A BR 9712548A
Authority
BR
Brazil
Prior art keywords
fetal
erythrocyte
identifying
kit
erythroblastic cell
Prior art date
Application number
BR9712548-2A
Other languages
English (en)
Inventor
Mitchell Golbus
Original Assignee
Applied Imaging Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Imaging Inc filed Critical Applied Imaging Inc
Publication of BR9712548A publication Critical patent/BR9712548A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Dispersion Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"PROCESSO PARA IDENTIFICAR UMA CéLULA ERITRóCITA OU ERITROBLáSTCA FETAL EM UMA AMOSTRA SANGUìNEA, KIT PARA IDENTIFICAçãO DE UMA CéLULA ERITRóCITA OU ERITROBLáSTICA NUCLEADA FETAL, E, KIT PARA SELEçãO OU ISOLAMENTO DE UMA SEQUêNCIA DE áCIDO NUCLéICO DENTRO DE UMA CéLULA ERITRóCITA NUCLEADA FETAL". é descrito um processo in vitro de identificação ou de isolamento de células fetais de uma amostra sanguínea. Eritrócitos ou eritroblastos nucleados fetais são identificados pelo uso de um anticorpo ou de um fragmento de anticorpo específico para hemoglobina embriónica ou uma cadeia de hemoglobina embriónica. Tendo sido identicadas as células fetais, elas podem ser tratadas para tornar disponíveis as proteínas ou os ácidos nucléicos fetais para a identificação ou a amplificação. Detecção da ocorrência ou da existência de proteínas ou ácidos nucléicos fetais selecionados permite um diagnóstico qualitativo ou quantitativo ou uma avaliação pré-natal, incluindo a determinação do sexo do feto, a determinação de anormalidades cromossómicas, de único gene ou de proteína, e a determinação da presenção ou da ausência de específicos genes, sequências de ácidos nucleícos ou de proteínas.
BR9712548-2A 1996-10-21 1997-10-20 Processo para identificar uma célula eritrócita ou eritroblástica fetal em uma amostra sanguìnea, kit para identificação de uma célula eritrócita ou eritroblástica nucleada fetal, e, kit para seleção ou isolamento de uma sequência de ácida nucléico dentro de uma célula eritrócita ou eritroblástica nucleada fetal. BR9712548A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/734,556 US5731156A (en) 1996-10-21 1996-10-21 Use of anti-embryonic hemoglobin antibodies to identify fetal cells
PCT/US1997/019447 WO1998018005A1 (en) 1996-10-21 1997-10-20 Use of anti-embryonic hemoglobin antibodies to identify fetal cells

Publications (1)

Publication Number Publication Date
BR9712548A true BR9712548A (pt) 1999-12-21

Family

ID=24952172

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712548-2A BR9712548A (pt) 1996-10-21 1997-10-20 Processo para identificar uma célula eritrócita ou eritroblástica fetal em uma amostra sanguìnea, kit para identificação de uma célula eritrócita ou eritroblástica nucleada fetal, e, kit para seleção ou isolamento de uma sequência de ácida nucléico dentro de uma célula eritrócita ou eritroblástica nucleada fetal.

Country Status (14)

Country Link
US (1) US5731156A (pt)
EP (1) EP1007965B1 (pt)
JP (1) JP4091123B2 (pt)
KR (1) KR100523381B1 (pt)
CN (1) CN1234117A (pt)
AT (1) ATE290210T1 (pt)
AU (1) AU735380B2 (pt)
BR (1) BR9712548A (pt)
CA (1) CA2269327A1 (pt)
DE (1) DE69732662T2 (pt)
HK (1) HK1031255A1 (pt)
IL (1) IL129382A (pt)
RU (1) RU2178703C2 (pt)
WO (1) WO1998018005A1 (pt)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509192B1 (en) * 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
US5629147A (en) * 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
DE69627183T2 (de) 1995-11-30 2004-01-29 Chromavision Med Sys Inc Verfahren zur automatischen bildanalyse biologischer proben
US6718053B1 (en) * 1996-11-27 2004-04-06 Chromavision Medical Systems, Inc. Method and apparatus for automated image analysis of biological specimens
ATE308755T1 (de) * 1997-03-08 2005-11-15 Univ Dundee Pränatale diagnostische verfahren in vitro
US5962234A (en) * 1997-10-20 1999-10-05 Applied Imaging Corporation Use of anti-embryonic epsilon hemoglobin antibodies to identify fetal cells
KR100691043B1 (ko) * 1998-05-09 2007-03-09 아이코니시스 인코포레이티드 컴퓨터 제어된 태아 세포 포함 희귀 세포 진단 방법 및 장치
FR2781055B1 (fr) * 1998-07-09 2000-10-13 Immunotech Sa Reactif et methode pour la permeabilisation et l'identification des erythrocytes
AU4745200A (en) * 1999-05-25 2000-12-12 Britta Christensen Isolation and culturing of fetal cells
US6692952B1 (en) * 1999-11-10 2004-02-17 Massachusetts Institute Of Technology Cell analysis and sorting apparatus for manipulation of cells
DE10035433C2 (de) * 2000-07-20 2002-07-18 Tuma Wolfgang Schonende Hochanreicherung von fetalen Zellen aus pripherem Blut und Verwendung derselben
CA2469878C (en) * 2001-12-11 2011-06-28 Netech Inc. Blood cell separating system
EP2359689B1 (en) 2002-09-27 2015-08-26 The General Hospital Corporation Microfluidic device for cell separation and use thereof
AU2003254755B2 (en) 2002-10-16 2007-12-20 Streck, Inc. Method and device for collecting and preserving cells for analysis
US20040214243A1 (en) * 2003-04-25 2004-10-28 Beckman Coulter, Inc. Differential determination of hemoglobins
WO2004113877A1 (en) * 2003-06-13 2004-12-29 The General Hospital Corporation Microfluidic systems for size based removal of red blood cells and platelets from blood
CA2557819A1 (en) * 2004-03-03 2005-09-15 The General Hospital Corporation Magnetic device for isolation of cells and biomolecules in a microfluidic environment
US7653260B2 (en) * 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) * 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system
US20070196820A1 (en) * 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US20070026413A1 (en) * 2005-07-29 2007-02-01 Mehmet Toner Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026414A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026415A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026417A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059680A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US20070026416A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20090181421A1 (en) * 2005-07-29 2009-07-16 Ravi Kapur Diagnosis of fetal abnormalities using nucleated red blood cells
US20070059774A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20070059718A1 (en) * 2005-09-15 2007-03-15 Mehmet Toner Systems and methods for enrichment of analytes
US20070059683A1 (en) * 2005-09-15 2007-03-15 Tom Barber Veterinary diagnostic system
US20070059719A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis
US20070059781A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
US20070059716A1 (en) * 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
ES2374686T3 (es) 2007-05-14 2012-02-21 Historx, Inc. Separación en compartimentos por caracterización de píxel usando agrupamiento de datos de imágenes.
JP5593221B2 (ja) * 2007-06-15 2014-09-17 ヒストロックス，インコーポレイテッド． 顕微鏡機器を標準化するための方法およびシステム
CA2604317C (en) 2007-08-06 2017-02-28 Historx, Inc. Methods and system for validating sample images for quantitative immunoassays
CA2596204C (en) * 2007-08-07 2019-02-26 Historx, Inc. Method and system for determining an optimal dilution of a reagent
WO2009029810A1 (en) * 2007-08-31 2009-03-05 Historx, Inc. Automatic exposure time selection for imaging tissue
US8137903B2 (en) 2007-12-20 2012-03-20 Cytyc Corporation Method for magnetic separation of red blood cells from a patient sample
CA2752838A1 (en) * 2008-02-18 2009-08-27 Genetic Technologies Limited Cell processing and/or enrichment methods
WO2010012002A1 (en) * 2008-07-25 2010-01-28 Saryna Medical Corporation Methods and systems for genetic analysis of fetal nucleated red blood cells
ES2573945T3 (es) * 2008-09-16 2016-06-13 Novartis Ag Cuantificación reproducible de expresión de biomarcadores
WO2010078194A1 (en) * 2008-12-30 2010-07-08 Streck, Inc. Method for screening blood using a preservative that may be in a substantially solid state form
US11634747B2 (en) * 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
EP2389455A4 (en) * 2009-01-26 2012-12-05 Verinata Health Inc METHODS AND COMPOSITIONS FOR IDENTIFYING A FETAL CELL
US8231007B2 (en) * 2009-01-29 2012-07-31 Wark Rickey E Static classifier cage
US8304187B2 (en) 2009-02-18 2012-11-06 Streck, Inc. Preservation of cell-free RNA in blood samples
EP2421955A4 (en) 2009-04-21 2012-10-10 Genetic Technologies Ltd METHODS OF OBTAINING F TAL GENETIC MATERIAL
IN2012DN00715A (pt) * 2009-06-24 2015-06-19 Health Corp Rambam
EP3103883A1 (en) * 2009-11-09 2016-12-14 Streck, Inc. Stabilization of rna in and extracting from intact cells within a blood sample
BR112012018166A2 (pt) 2010-01-21 2015-09-15 Biocep Ltd separação magnética de células raras.
US8774488B2 (en) 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
CA2796087A1 (en) * 2010-04-20 2011-10-27 Ventana Medical Systems, Inc. Two-color chromogenic in situ hybridization
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
RU2636220C2 (ru) * 2011-12-23 2017-11-21 Депуи Синтез Продактс, Инк. Обнаружение клеток, полученных из ткани пуповины человека
EP2864472A4 (en) * 2012-06-20 2015-12-30 Celula Inc MATERIALS AND METHODS FOR TREATING CELLULAR POPULATIONS
CA2876692C (en) 2012-06-22 2022-05-24 Quantrx Biomedical Corporation Method for obtaining fetal cells and fetal cellular components
CN109554350B (zh) * 2012-11-27 2022-09-23 儿童医疗中心有限公司 用于胎儿血红蛋白再诱导的靶向bcl11a远端调控元件
SG11201507967WA (en) * 2013-03-27 2015-10-29 Theranos Inc Methods, devices, and systems for sample analysis
WO2015013244A1 (en) 2013-07-24 2015-01-29 Streck, Inc. Compositions and methods for stabilizing circulating tumor cells
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
CN104977284B (zh) * 2015-07-03 2018-05-29 石莹 一种胎儿有核红细胞的捕获及鉴定方法
KR101794218B1 (ko) * 2015-08-19 2017-11-07 인제대학교 산학협력단 비침습적 산전 진단을 위한 산모 혈액 내 유핵 적혈구의 농축 분리 방법
WO2017057076A1 (ja) * 2015-09-28 2017-04-06 富士フイルム株式会社 有核赤血球の取得方法および有核赤血球の識別方法
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
US11506655B2 (en) 2016-07-29 2022-11-22 Streck, Inc. Suspension composition for hematology analysis control
JP6234542B1 (ja) 2016-12-27 2017-11-22 株式会社 ＴＬ Ｇｅｎｏｍｉｃｓ 胎児細胞由来染色体ｄｎａの取得方法
EP3699587B1 (en) 2017-10-19 2022-04-27 TL Genomics Inc. Chip for cell classification
CN109115584A (zh) * 2018-09-10 2019-01-01 首都医科大学附属北京妇产医院 一种检测红细胞中血红蛋白f的检测试剂及其应用
CN114430805A (zh) 2019-07-15 2022-05-03 美纳里尼生物标记新加坡有限公司 分离、检测和分析胎儿细胞的组合物和方法
CN111948404B (zh) * 2020-08-03 2023-04-07 融智生物科技（青岛）有限公司 用于筛查地中海贫血的特征蛋白标记组合物、质谱模型及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007660A1 (en) * 1989-11-13 1991-05-30 Children's Medical Center Corporation Non-invasive method for isolation and detection of fetal dna
CA2140278C (en) * 1992-07-17 2009-03-17 Morteza Asgari Enriching and identyfing fetal cells in maternal blood for in situ hybridization
US5457024A (en) * 1993-01-22 1995-10-10 Aprogenex, Inc. Isolation of fetal erythrocytes
WO1995003431A1 (en) * 1993-07-19 1995-02-02 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5580724A (en) * 1994-03-25 1996-12-03 Board Of Regents, The University Of Texas System Differential expansion of fetal stem cells in maternal circulation for use in prenatal genetic analysis

Also Published As

Publication number Publication date
AU4920097A (en) 1998-05-15
HK1031255A1 (en) 2001-06-08
JP2001502805A (ja) 2001-02-27
DE69732662T2 (de) 2005-12-29
WO1998018005A1 (en) 1998-04-30
US5731156A (en) 1998-03-24
EP1007965A4 (en) 2000-06-14
IL129382A0 (en) 2000-02-17
KR100523381B1 (ko) 2005-10-24
DE69732662D1 (de) 2005-04-07
CA2269327A1 (en) 1998-04-30
EP1007965B1 (en) 2005-03-02
CN1234117A (zh) 1999-11-03
EP1007965A1 (en) 2000-06-14
JP4091123B2 (ja) 2008-05-28
KR20000052662A (ko) 2000-08-25
IL129382A (en) 2002-09-12
RU2178703C2 (ru) 2002-01-27
AU735380B2 (en) 2001-07-05
ATE290210T1 (de) 2005-03-15

Similar Documents

Publication Publication Date Title
BR9712548A (pt) Processo para identificar uma célula eritrócita ou eritroblástica fetal em uma amostra sanguìnea, kit para identificação de uma célula eritrócita ou eritroblástica nucleada fetal, e, kit para seleção ou isolamento de uma sequência de ácida nucléico dentro de uma célula eritrócita ou eritroblástica nucleada fetal.
Bianchi Circulating fetal DNA: its origin and diagnostic potential—a review
US8754014B2 (en) Methods for selecting oocytes and competent embryos with high potential for pregnancy outcome
WO2002055985A3 (en) Methods and reagents for identifying rare fetal cells in the material circulation
US20080108071A1 (en) Methods and Systems to Determine Fetal Sex and Detect Fetal Abnormalities
WO1987003910A1 (en) Cellular method for determining tissue of origin
CN106191233B (zh) 多重实时定量pcr检测染色体非整倍体的试剂盒及其应用
Edlow et al. Tracking fetal development through molecular analysis of maternal biofluids
US9090938B2 (en) Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
MXPA96004278A (es) Expansion diferencial de celulas de baston fetalesen la circulacion materna para usarse en analisisgenetico prenatal.
JP2005506849A5 (pt)
WO2005047532A1 (en) Improved method of performing genetic analyses on reproductive tract cell samples
NO994358L (no) FramgangsmÕte for Õ identifisere eller isolere röde blodlegemer fra embryo eller foster
Zhang et al. Quantitative abnormalities of fetal trophoblast cells in maternal circulation in preeclampsia
EP3412769B1 (en) Method for separating target cell from blood sample and use thereof
EP3202912A1 (en) Noninvasive method and system for determining fetal chromosomal aneuploidy
Chiu et al. Non-invasive prenatal diagnosis: on the horizon?
CN110938700B (zh) 一种评价或辅助评价卵巢细胞的方法及其使用的标志物
Sonek et al. Identification of fetal aneuploidy with dual‐probe fluorescence in situ hybridization analysis in circulating trophoblasts after enrichment using a high‐sensitivity microfluidic platform
Tungwiwat et al. Accuracy of fetal gender detection using a conventional nested PCR assay of maternal plasma in daily practice
Fukushima et al. The application of magnetic cell sorter (MACS) to detect fetal cells in maternal peripheral blood
WO2024058850A1 (en) Rna-facs for rare cell isolation and detection of genetic variants
Torok et al. Evaluation of Possible Processing Time Effects on the Global N-Glycosylation Profile of Human Blood Samples
JP2018105645A (ja) 希少細胞の検出方法
Gramatiuk et al. The current fetal cell-free DNA in the blood of pregnancies without complications and with gestational and diabetes 2 type mellitus

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]